THERAPEUTIC AGENT FOR NON-ALCOHOLIC FATTY LIVER DISEASE AND/OR NON-ALCOHOLIC STEATOHEPATITIS

• Main Authors: MIYAJIMA MASATO, HIGA TATSUNORI
• Format: Patent
• Language: English
• Published: 08.07.2013
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

PROBLEM TO BE SOLVED: To provide a therapeutic agent for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis, containing bacterial complex including photosynthetic bacteria as an active ingredient.SOLUTION: The therapeutic agent for the non-alcoholic fatty liver disease and/or the non-alcoholic steatohepatitis includes the bacterial complex comprising the photosynthetic bacteria, lactic acid bacteria and yeast as an active ingredient. The photosynthetic bacteria are preferably Rhodopseudomonas palustris. The bacterial complex comprising the photosynthetic bacteria, the lactic acid bacteria and the yeast act as probiotics, and mitigate the symptom of hepatitis induced by methionine-choline-deficient diet by being orally administered. When the bacterial complex is administered to a leptin receptor-deficient mouse, a serum insulin level can be reduced.